QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAPharmaceutical-GradeChina Warehouse
What is BLEND 300 (Trenbolone Acetate 100mg + Drostanolone Propionate 100mg + Testosterone Propionate 100mg)?
BLEND 300 is a short-ester triple-compound research preparation combining Trenbolone Acetate 100mg/mL, Drostanolone Propionate 100mg/mL, and Testosterone Propionate 100mg/mL in a single oil-based injectable solution. All three esters share a fast-acting short-ester profile, making this a standardised multi-compound pharmacokinetic research formulation. Research use only.
Research Applications
Multi-Compound Pharmacokinetics
Simultaneous serum profiling of three anabolic compounds — peak, half-life, and clearance
Androgen Receptor Binding Studies
Comparative AR affinity: trenbolone (~3×), drostanolone (~3×), testosterone (reference)
Short-Ester Release Kinetics
Rapid ester hydrolysis, Cmax timing, AUC for propionate/acetate esters
SHBG Displacement Research
Free androgen availability — drostanolone SHBG competition models
Anabolic/Androgenic Ratio Research
Tissue-selective androgenic index studies across three distinct androgen scaffolds
Quick Specs
| Form | Injectable solution |
| Concentration | 300mg/mL |
| CAS | 10161-34-9 / 521-12-0 / 57-85-2 |
| Molecular Formula | TrenAce C₂₀H₂₄O₃ + Masto-P C₂₃H₃₆O₃ + Test-P C₂₂H₃₂O₃ |
| MW | 372.5 / 360.5 / 344.5 |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Vehicle | Pharmaceutical-grade oil (USP/BP) |
| Storage | Room temperature 15–25°C | Protect from light | Do not freeze |
| Shelf Life | 24 months (unopened) |
